EndoCrine Biotherapeutics

United States
Berkeley, California, United States

Company profile

EndoCrine Biotherapeutics company profile

EndoCrine Biotherapeutics develops early-stage diabetes drugs to improve pancreatic cell health and advance stem cell.

Business identity

Operating status
Active
Company type
For Profit
Founded
2021-01-01

Headquarters

Headquarters
Berkeley, California, United States
Postal code
94704
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$105K
Last funding
Pre Seed / $105K / 2021-04-07
Last equity funding
Pre Seed / $105K
Investors
1

Founders and investors

Investors

SkyDeck Berkeley

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.